Immunocore Holdings IMCR
NASDAQ IMCR
$29.71 -0.83 (-2.72%)
At close: Oct 2, 2026 · 4:00 PM EDT

Immunocore Holdings (IMCR) Cash & Equivalents (2019 - 2026)

Updated

Immunocore Holdings (IMCR) posted Cash & Equivalents of $484.92 million for Q2 2026, down 0.6% from $487.93 million a year earlier but up 7.1% from the prior quarter.

Analysis

Immunocore Holdings (IMCR) Cash & Equivalents (2019 - 2026) Analysis & Trends

At the end of FY2025, Immunocore Holdings' Cash & Equivalents came in at $467.71 million, up 2.6% from FY2024.

  • Annual Cash & Equivalents has increased for six consecutive years, with a five-year compound annual growth rate of 22.3% (FY2020 to FY2025).
  • In prior years, Immunocore Holdings' Cash & Equivalents was $455.73 million in FY2024 (+3.0%), $442.63 million in FY2023 (+10.0%), $402.47 million in FY2022 (+23.0%) and $327.3 million in FY2021 (+91.1%).
  • Quarterly Cash & Equivalents has run from a low of $262.02 million in Q2 2022 to a high of $832.82 million in Q1 2024 over five years.
  • On a year-over-year basis, Cash & Equivalents increased in two of the last seven quarters, with an average decline of 7.6%.
  • The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q4 2021, with growth of 87.2%; the weakest was Q1 2025, with a decline of 42.7%.
  • According to Business Quant data, Cash & Equivalents for the three prior quarters was $452.68 million (Q1 2026), $467.71 million (Q4 2025) and $498.41 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.42 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.89 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 976.00 Mn
10 Immunocore Holdings 1.53 Bn -1.95 Bn 114.84 Mn 484.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 484.92 Mn
Mar 31, 2026 452.68 Mn
Dec 31, 2025 467.71 Mn
Sep 30, 2025 498.41 Mn
Jun 30, 2025 487.93 Mn
Mar 31, 2025 476.85 Mn
Dec 31, 2024 455.73 Mn
Sep 30, 2024 537.77 Mn
Jun 30, 2024 504.99 Mn
Mar 31, 2024 832.82 Mn
Dec 31, 2023 442.63 Mn
Jun 30, 2023 428.39 Mn
Dec 31, 2022 390.04 Mn
Sep 30, 2022 409.18 Mn
Jun 30, 2022 262.02 Mn
Dec 31, 2021 320.67 Mn
Sep 30, 2021 353.68 Mn
Dec 31, 2020 171.28 Mn
Dec 31, 2019 95.10 Mn
API Access

Immunocore Holdings Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IMCR&period=max&api_key=YOUR_API_KEY